GamaMabs Pharma, a French biotechnology company focused on cancer treatment, has raised €15m for Edmond de Rothschild Investment Partners (EdRip) and its previous backers.
Oddo BHF Private Equity Secondaries Fund has a focus on secondary transactions ranging from €5m to €50m
Although the coronavirus pandemic has set back plans for many GPs, a number of buyout and venture vehicles are on the road in the DACH region
Firm is already nearing the overall amount raised by its €413m predecessor
Acquisition of the France-based company is Silver Lake's first European acquisition of 2020